|Synta Pharmaceuticals, Inc.||(NQ: SNTA)|
Official Closing Price / Updated: /
May 25, 2013
My notes from the Synta webcast at the Lazard conference on 11/15 are below For company info featuring ganestespib HSP90 inhibitor can see SNTA research page For complete...(read more)
A critical role for the tissue distribution profile in heat shock protein (Hsp) 90 inhibitor-induced ocular toxicity in rats Link In addition to regulating a number of...(read more)
Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results and operational...(read more)
Synta Pharmaceuticals (SNTA) Company Overview
There is no analysis for SNTA yet. But you can go to Wikinvest to help create one!